By: Tomas Ronolski - AllPennyStocks.com News

Friday, December 5, 2014

The U.S. Centers for Disease Control and Prevention has offered a warning to brace for what could be a nasty flu season this year. The CDC warning is related to the particular type of influenza strains that this year’s flu shots, which are meant to prime a person’s immune system to combat three or four different flu viruses, will work best against. What CDC scientists are seeing so far is that H3N2 viruses are the most dominant this year. Typically, when the H3 variety is the leading type, the flu season tends to be worse. Flu vaccines are the first recommended line of protection. For those looking for additional defense, air cleaners are an option, including the RxAir® Air Purification Systems of UV Flu Technologies Inc.(OTCBB:UVFT). There are other purifiers out there that use new technologies, such as PlamaWave® technology in the Winix systems, to neutralize bacteria and viruses, but they don’t seem to emphasize the destruction of airborne pathogens the way UV Flu Technologies does with their patented technology.

The company trumpets their FDA-cleared (as a Class 2 medical device) RxAir Purification System to destroy “more than 99% of airborne bacteria and viruses, including the flu, H1N1, SARS, pneumonia, MRSA, strep, TB, measles and the common cold, as proven by independent FDA- and EPA-certified lab testing.”

The RxAir system began being sold last month through RxAir.com, as well as on Amazon, Rakuten and SleepRestFully websites. The product is listed at $498.00, with an extended warranty package, including free replacement filters for five years, bumping the price to $598.00.

UV Flu Technologies also markets the Rx3000 (also a FDA-cleared Class 2 medical device), which is used in more than 400 hospitals, including the likes of MD Anderson Cancer Center and Children’s Hospital and Medical Center. A report on ABC News earlier this year featuring infectious disease specialist Dr. Mark Sawyer of Rady Children’s Hospital in San Diego showed the Rx3000, with the doctor saying the Rx3000 has “a special filter which takes out any infectious agent.” The report was centered on the measles outbreak in the U.S., which at 603 confirmed cases reported by the CDC through October 31, is the highest number of cases since measles elimination was documented in the U.S. in 2000.

The secret to contaminant destruction in UV Flu Technologies products rests in the “kill chamber” of the devices, which forces bacteria and viruses to extended exposure to scientifically chosen UV-C lights, penetrating the pathogen's membrane to terminate them on the first pass.

"Germicidal UV air purifiers are the best way to combat the airborne pathogens on a continuous basis,” Bryan Stone, Chief of Medicine, Desert Regional Medical Center, in a UVFT press release on Friday. “We needed a new magic bullet this season and this one makes so much sense."

A quick look at regulatory filings shows that revenue at UV Flu Technologies has been tepid, to say the least, totaling $146,195 in the nine months to June 30. The question is can RxAir provide a shot in the arm (no flu pun intended)? Investors will be watching sales performance of the new product to see if it can deliver a lift to shares that are sitting at 3 cents, equating to a market capitalization of only $2.2 million. Just after Friday’s opening bell, shares have dipped to 2.5 cents each, albeit on less than 10,000 in volume.

Copyright © 2014 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.